Acorn Regulatory’s Top 100 Articles

What The Newspapers Are Saying About The EMA Issue

What The Newspapers Are Saying About The EMA Issue

The applications from potential host countries have been received and the ‘horse trading’ has begun.  The decision on the EMA… Read more

The Brexit Transition Period

Blog: The Brexit Transition Period & The Life Sciences Sector

In this blog, Brian Cleary looks at the comments of British Chancellor Philip Hammond regarding the Brexit Transition Period.

The Tick-Tock of the EMA Clock

The Tick-Tock of the EMA Clock

July 31st marks the final date for submission of proposals by member states to host the European Medicines Agency. Last… Read more

clinical trials marketing authorisation - Acorn Regulatory

Are You Ready for the Falsified Medicines Directive?

The Falsified Medicines Directive (FMD) was published in 2011 with the aim of preventing falsified medicines from entering the pharmaceutical… Read more

Applications To Host European Medicines Agency Must Be Submitted by July 31st

Reports in this morning’s Financial Times (23/05/17) state that applications to host the European Medicines Agency will have to be… Read more

Changing EU Authorised Representative

Brexit – Moving A Marketing Authorisation

The UK’s decision to leave the EU will cause considerable upheaval for holders of marketing authorisations.  As the recognised Brexit… Read more

5 Steps To Obtain A Wholesale Distribution Authorisation Licence

The WDA process is complex.  Indeed, many companies turn to us to manage the application process on their behalf. Here,… Read more

SWOT Analysis of the Bonn Bid for the European Medicines Agency

SWOT Analysis of the Bonn Bid for the European Medicines Agency

Bonn, once a city that played a significant role in late 20th century world affairs, has not featured in news… Read more

eCTD dossier - Acorn Regulatory

Simplified Adverse Event Reporting in Europe – Are You Prepared for the Switch Over?

Since the introduction of the pharmacovigilance legislation in 2010, a commitment to a simplified approach to adverse event reporting was… Read more

Contact us and enjoy a faster, smoother journey through the maze of European Pharmaceutical and Medical Device legislation with us as your expert guide.
©2021 Acorn Regulatory Consultancy Services Ltd. Company Registration No. 397294 VAT Registered No. IE 6417294V
Designed by